Mycobacterium marinum MMAR_2380, a predicted transmembrane acyltransferase, is essential for the presence of the mannose cap on lipoarabinomannan by Driessen, Nicole N. et al.
Mycobacterium marinum MMAR_2380, a
predicted transmembrane acyltransferase, is
essential for the presence of the mannose cap on
lipoarabinomannan
Nicole N. Driessen,
1 Esther J. M. Stoop,
1 Roy Ummels,
1
Sudagur S. Gurcha,
2 Arun K. Mishra,
2 Ge ´rald Larrouy-Maumus,
3,4
Je ´ro ˆme Nigou,
3,4 Martine Gilleron,
3,4 Germain Puzo,
3,4 Janneke
J. Maaskant,
1 Marion Sparrius,
1 Gurdyal S. Besra,
2 Wilbert Bitter,
1
Christina M. J. E. Vandenbroucke-Grauls
1 and Ben J. Appelmelk
1
Correspondence
Ben J. Appelmelk
bj.appelmelk@vumc.nl
Received 22 December 2009
Revised 8 July 2010
Accepted 4 August 2010
1Department of Medical Microbiology and Infection Control, VU University Medical Center,
1081 BT Amsterdam, The Netherlands
2School of Biosciences, University of Birmingham, Edgbaston B15 2TT, UK
3CNRS, IPBS (Institut de Pharmacologie et de Biologie Structurale), 205 Route de Narbonne,
F-31077 Toulouse, France
4Universite ´ de Toulouse, UPS, IPBS, F-31077 Toulouse, France
Lipoarabinomannan (LAM) is a major glycolipid in the mycobacterial cell envelope. LAM consists of
a mannosylphosphatidylinositol (MPI) anchor, a mannan core and a branched arabinan domain. The
termini of the arabinan branches can become substituted with one to three a(1A2)-linked mannosyl
residues, the mannose cap, producing ManLAM. ManLAM has been associated with a range of
different immunomodulatory properties of Mycobacterium tuberculosis during infection of the host.
In some of these effects, the presence of the mannose cap on ManLAM appears to be crucial for its
activity. So far, in the biosynthesis of the mannose cap on ManLAM, two enzymes have been
reported to be involved: a mannosyltransferase that adds the first mannosyl residue of the mannose
caps to the arabinan domain of LAM, and another mannosyltransferase that elongates the mannose
cap up to three mannosyl residues. Here, we report that a third gene is involved, MMAR_2380,
which is the Mycobacterium marinum orthologue of Rv1565c. MMAR_2380 encodes a predicted
transmembrane acyltransferase. In M. marinum DMMAR_2380, the LAM arabinan domain is still
intact, but the mutant LAM lacks the mannose cap. Additional effects of mutation of MMAR_2380
on LAM were observed: a higher degree of branching of both the arabinan domain and the mannan
core, and a decreased incorporation of [1,2-
14C]acetate into the acyl chains in mutant LAM as
compared with the wild-type form. This latter effect was also observed for related lipoglycans, i.e.
lipomannan (LM) and phosphatidylinositol mannosides (PIMs). Furthermore, the mutant strain
showed increased aggregation in liquid cultures as compared with the wild-type strain. All
phenotypic traits of M. marinum DMMAR_2380, the deficiency in the mannose cap on LAM and
changes at the cell surface, could be reversed by complementing the mutant strain with
MMAR_2380. Strikingly, membrane preparations of the mutant strain still showed enzymic activity
for the arabinan mannose-capping mannosyltransferase similar to that of the wild-type strain.
Although theexact function of MMAR_2380remains unknown,we showthat theprotein is essential
for the presence of a mannose cap on LAM.
Abbreviations: Ara6, hexaarabinofuranoside; Araf, arabinofuranosyl unit; AraLAM, LAM with linked arabinosyl units; BCA, bicinchoninic acid; CE, capillary
electrophoresis; LAM, lipoarabinomannan; LM, lipomannan; ManLAM, mannose-capped LAM; Manp, mannopyranosyl residue; MPI, mannosylphos-
phatidylinositol; PIMs, phosphatidylinositol mannosides; PIM2, phosphatidylinositol dimannosides; PIM4, phosphatidylinositol tetramannosides; PIM6,
phosphatidylinositol hexamannosides; PM–CW, plasma membrane–cell wall domain.
Six supplementary figures and a supplementary table, with supplementary references, are available with the online version of this paper.
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The complex mycobacterial cell envelope contains an
exceptionally high amount of lipids. One of the major
glycolipids present is lipoarabinomannan (LAM) (Briken
et al., 2004; Chatterjee & Khoo, 1998; Nigou et al., 2002,
2003). With its mannosylphosphatidylinositol (MPI)
anchor, LAM is probably inserted in both the cytoplasmic
membrane and the outer membrane (Hoffmann et al.,
2008; Pitarque et al., 2008). The glycan portion of LAM
comprises a mannan core, which consists of a(1A6)-linked
mannosyl residues substituted at some positions with
single a(1A2)-linked mannoses, and an arabinan domain
consisting of a(1A5)-linked arabinose (see Supplementary
Fig. S1). This latter domain is branched with side chains
that always end in b(1A2)-linked arabinosyl units
(AraLAM). In mannose-capped LAM (ManLAM), a part
of these terminal arabinosyl residues is substituted with an
a(1A5)-linked mannosyl residue which can be further
elongated by the addition of one or two a(1A2)-linked
mannosyl residues, forming the mannose cap (Supple-
mentary Fig. S1). Whether mannose caps are present on
LAM depends on the Mycobacterium species (Pitarque
et al., 2005).
Several immunomodulating properties of LAM have been
reported which could codetermine the host–pathogen
interaction during infection with pathogenic mycobacteria,
such as Mycobacterium tuberculosis. Some of these have
been linked specifically to the presence of the mannose
cap on LAM, e.g. the binding of ManLAM to pattern
recognition receptors such as the dendritic cell-specific
intercellular adhesion molecule-3-grabbing nonintegrin
(DC-SIGN) (Geijtenbeek et al., 2003; Maeda et al., 2003)
and the macrophage mannose receptor (MMR) (Schlesinger
et al., 1994), and its role in phagosome maturation arrest
(Kang et al., 2005; Welin et al., 2008).
So far, two mannosyltransferases have been identified as
being involved in the biosynthesis of the mannose cap on
ManLAM. The first, encoded by Rv1635c, adds the first
mannosyl residue of the mannose cap to the non-reducing
arabinan termini (Dinadayala et al., 2006). Rv2181 encodes
the second, cap-elongating mannosyltransferase, which
besides lengthening of the mannose cap, substitutes the
mannan core of LAM with the single a(1A2)-linked
mannose moieties (Kaur et al., 2006, 2008). Both enzymes
use polyprenylphosphomannose (PPM) as a sugar donor
(Appelmelk et al., 2008; Kaur et al., 2006). A potential
glycosyltransferase function of these enzymes has been
predicted using bioinformatics tools. Although very
successful, this approach is biased towards finding
glycosyltransferases directly involved in the biosynthesis
of glycolipids or glycoproteins, and proteins that exert
more unexpected functions may be missed.
In an alternative approach to identify novel genes with a role
in the biosynthesis of ManLAM, we have used a colony blot
screen of a transposon-insertion mutant library in Myco-
bacterium marinum in which single-transposon mutants
were probed with mannose cap-recognizing mAb 55.92.1A1
(Appelmelk et al., 2008). As recently described, this screen
yielded the mutant in MMAR_2439, the M. marinum
orthologue of Rv1635c. Subsequent mannosyltransferase
assays and chemical analysis confirmed that the function of
MMAR_2439 is the addition of the first mannosyl residue of
the mannose cap to LAM, identical to Rv1635c (Appelmelk
et al., 2008).
We have extended our search using the screening approach
with the mannose cap-recognizing mAb. In this paper, we
reveal a third gene involved in the biosynthesis of the
mannose cap on LAM. In M. marinum DMMAR_2380, the
LAM molecule is still intact, apart from lacking its
mannose cap. Additional effects of the mutation of
MMAR_2380 were seen in a higher degree of branching
of both the arabinan domain and the mannan core in
mutant LAM, decreased [1,2-
14C]acetate incorporation in
the acyl chains of mutant LAM and related lipoglycans, and
an altered cell surface of the mutant strain as compared
with wild-type M. marinum. MMAR_2380 encodes a
predicted transmembrane acyltransferase, and here we
explored potential roles for MMAR_2380 in the biosyn-
thesis of LAM in M. marinum.
METHODS
Bacterial strains and growth conditions. M. marinum strain E11
(Puttinaowarat et al., 1999) and Mycobacterium smegmatis mc
2155
were grown in Middlebrook 7H9 broth (Difco) with 10%
Middlebrook albumin dextrose catalase (ADC) enrichment (BBL)
and 0.05% (v/v) Tween 80, or on Middlebrook 7H10 agar (Difco)
with 10% Middlebrook oleic acid albumin dextrose catalase (OADC)
enrichment (BBL) at 30 and 37 uC, respectively. Escherichia coli DH5a
was grown on LB at 37 uC. Mycobacterial growth was measured by
determining OD600 with a UV/visible spectrophotometer (Jenway).
The concentrations of antibiotics used were 25 mg kanamycin ml
21
and 50 mg hygromycin ml
21 for mycobacteria, and 100 mg hygro-
mycin ml
21 for E. coli.
Immunoblotting assay. Bacteria were grown until the late-
exponential phase and disrupted with a Beadbeater (BioSpec).
Protein concentration was measured with a bicinchoninic acid
(BCA) Protein Assay (Pierce). Supernatants were run on a 10%
SDS-PAGE gel and immunostained after electroblotting on a PVDF
membrane (Millipore). Murine mAbs of the IgM class were used.
mAb F30-5 recognizes the branches of the arabinan domain of LAM
(Appelmelk et al., 2008; Kolk et al., 1984). mAb 55.92.1A1 binds the
mannose cap on ManLAM (Appelmelk et al., 2008). First the PVDF
membranes were incubated in 0.5% (w/v) blocking reagent
(Boehringer) for 1 h at 37 uC, followed by another incubation
of 2 h with the mAb diluted in 1:1 blocking buffer and PBS+0.05%
(v/v) Tween 80 (PBST). After thorough washing in PBST, the
membranes were incubated with horseradish peroxidase (HRP)-
labelled goat anti-mouse IgM (American Qualex) in PBST with 0.5%
(v/v) normal goat serum. After washing, the membranes were stained
with 4-chloro-1-naphthol (4-CN; Bio-Rad) and 3,39-diamino-
benzidine.4HCl (DAB; Sigma).
Identification of a novel M. marinum mutant deficient in
the biosynthesis of the mannose cap on LAM. A transposon
insertion mutant library was created in M. marinum E11 with the
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specificity (dinucleotide TA) (Rubin et al., 1999). The transposon was
introduced via phagemid QMycoMarT7, as described by Sassetti et al.
(2001). Mutants selected on kanamycin were screened in a colony blot
assay for the absence of the mannose cap on LAM using mAb
55.92.1A1, as described previously (Appelmelk et al., 2008). In brief,
single colonies were transferred to PVDF membranes with sterile
toothpicks, after which the membranes were baked for 1 h at 70 uC
and subsequently treated as in the immunoblotting assay described
above. Mutants that were repeatedly negative with 55.92.1A1 in
colony blots were examined further by SDS-PAGE and immuno-
staining. The location of the transposon insertion was determined by
ligation-mediated PCR, as described previously (Abdallah et al.,
2006). The exact insertion position of the transposon in gene
MMAR_2380 was confirmed by standard PCR with the pMyco1-
primer and a second primer, cap-RV, which binds about 210 bp
downstream from MMAR_2380. The PCR product was sequenced on
an ABI Prism 300 DNA sequencer (Applied Biosystems). To
determine the direction of the kanamycin-resistance cassette in the
transposon in MMAR_2380, two primers were used, MMAR_2380-
FW and MMAR_2380-RV, with a binding site upstream or
downstream of the transposon in gene MMAR_2380, respectively,
and two primers binding to sequences within the transposon (the
kanamycin cassette), Kana-FW and Kana-RV. See Supplementary
Table S1 for primer sequences.
Complementation of the M. marinum DMMAR_2380 mutant
strain. MMAR_2380 was amplified from genomic M. marinum E11
wild-type DNA with primers cap-FW and cap-RV (Supplementary
Table S1) using the Expand High Fidelity PCR kit (Roche). The
obtained PCR product (2973 bp) was cloned into pCRII-TOPO. This
plasmid was digested with HindIII and EcoRV and the fragment was
ligated into HindIII/EcoRV-digested pSMT3-eGFP (Abdallah et al.,
2006). In the resulting plasmid (pSMT3-eGFP-MMAR_2380), the
gene of interest was located behind the GFP gene under the control of
heat-shock promoter 60 (HSP60). The complementation plasmid was
isolated from E. coli DH5a cells using the QIAprep Miniprep kit
(Qiagen) and electroporated into M. marinum DMMAR_2380.
Transformants (M. marinum DMMAR_2380 comp.) were selected
on hygromycin.
Chemical analysis of the mannose cap on LAM. The presence of
the mannose cap in M. marinum wild-type and M. marinum
DMMAR_2380 strains was analysed by capillary electrophoresis
(CE), as described previously (Appelmelk et al., 2008; Nigou et al.,
2000). In brief, purified LAM was partially degraded by controlled
acid hydrolysis (0.1 M HCl for 20 min at 110 uC), and the
oligosaccharides liberated were tagged with the fluorescent label 8-
aminopyrene-1,3,6-trisulfonate (APTS). During CE, the labelled
oligosaccharides were separated and peaks detected by laser-induced
fluorescence, and elution times were compared with the appropriate
standards.
Mannosyltransferase assay. Membranes of M. marinum E11 wild-
type, and the DMMAR_2380 and DMMAR_2380 complemented
strains were prepared as follows: mycobacterial cells (10 g wet weight)
were washed and resuspended in 30 ml buffer A, containing 50 mM
MOPS (adjusted to pH 8.0 with KOH), 5 mM b-mercaptoethanol
and 10 mM MgCl2 at 4 uC and subjected to probe sonication
(Soniprep 150, MSE Sanyo; 1 cm probe) for a total time of 10 min in
60 s pulses with 90 s cooling intervals between pulses. The sonicate
was centrifuged at 27000 g for 20 min at 4 uC. Membrane fractions
were obtained by centrifugation of the clarified lysate at 100000 g for
1 h at 4 uC. The supernatant was carefully removed and the
membranes gently resuspended in buffer A at a protein concentration
of 20 mg ml
21. Protein concentrations were determined using the
BCA Protein Assay Reagent kit (Pierce) (Lee et al., 1998). Assay
conditions consisted of buffer A, 1 mM ATP, membranes (500 mg),
0.1 mM decaprenyl phosphate (stored in 1% CHAPS as a 1 mM
stock solution), acceptor Ara6 (1 mM) and GDP-[
14C]mannose
[0.25 mCi (9.25 kBq), 11 GBq mmol
21, Amersham] to a final reaction
volume of 120 ml. Ara6 is synthetic aminooctyl-linked hexaarabino-
furanoside, a motif representing the terminal, non-reducing part of
LAM (Gadikota et al., 2003). The reaction mixtures were then
incubated at 37 uC for 1 h. The enzymically synthesized products
were extracted using ‘E-soak’ (water:ethanol:diethyl-ether:pyrid-
ine:ammonium hydroxide; 15:15:5:1:0.017 by vol.), which was
added to the incubation tubes. These were mixed for 30 min and then
centrifuged at 18000 g. The supernatant was recovered and dried
under reduced pressure with a Genevac EZ-2 evaporator, resuspended
in water (1 ml) and loaded onto a pre-equilibrated Alltech C18 Sep-
Pak cartridge (600 mg). The cartridge was washed with 5 ml water,
and the enzymically synthesized products were eluted with methanol
(5 ml) and subsequently dried under vacuum as described above. The
dried eluate was resuspended in water (1 ml) and loaded onto a pre-
equilibrated Supelco strong anion exchange (SAX) cartridge, which
was washed with 5 ml water. The water eluate was collected, dried
under vacuum and resuspended in 200 ml water, and contained the
14C-mannosylated acceptor Ara6 product. The total c.p.m. of
recovered radiolabelled material with this two-step separation
protocol was measured by scintillation counting of 10% of the
labelled material in 10 ml EcoScintA (National Diagnostics). The
incorporation of [
14C]mannose was determined by subtracting counts
present in control assays (reaction components incubated in the
absence of acceptor Ara6) (Appelmelk et al., 2008).
NMR analysis of the mannose cap, arabinan domain and
mannan core of LAM. NMR spectra of LAM from M. marinum
wild-type and M. marinum DMMAR_2380 were recorded on a Bruker
DMX-500 NMR spectrometer equipped with a double resonance
(1H/X)-BBi z-gradient probe head. All samples were exchanged in
D2O (99.97% D, Euriso-top), with intermediate lyophilization, and
then dissolved in 0.5 ml D2O and analysed at 313 K. The
1H and
13C
NMR chemical shifts were referenced relative to internal acetone at
2.225 and 34.00 p.p.m. respectively. All the details concerning NMR
sequences used and experimental procedures have been described in
previous studies (Gilleron et al., 2000).
Glycosidic linkage analysis of LAM. Glycosyl linkage composition
was performed according to the modified procedure of Ciucanu &
Kerek (1984). The per-O-methylated LAM was hydrolysed using
500 ml 2 M trifluoroacetic acid (TFA) at 110 uC for 2 h, reduced
using 350 ml1 0 m gm l
21 sodium borodeuteride [NaBD4 (1 M
NH4OH:C2H5OH, 1:1, v/v)] and per-O-acetylated using 300 ml
acetic anhydride for 1 h at 110 uC. The resulting alditol acetates were
solubilized in cyclohexane before analysis by GC and GC/MS.
[1,2-
14C]Acetate incorporation in total lipids. M. marinum strains
were grown as described above and metabolically labelled using 5 mCi
ml
21 [1,2-
14C]acetate [50–62 mCi mmol
21(1850–2294 MBq mmol
21),
GE Healthcare, Amersham Bioscience] at OD600 0.4, and cultures were
grown for a further 4 h at 37 uC with gentle shaking. Cells were
harvested by centrifugation and washed once with PBS, and a small-
scale apolar and polar lipid extraction was performed as described by
Dobson et al. (1985). The lipid extracts were dried and resuspended in
CHCl3:CH 3OH (2:1), and equal amounts of crude lipid
(25000 c.p.m.) were applied to the corners of 6.666.6 cm pieces of
Merck 5554 aluminium-backed TLC plates. The plates were developed
using solvent system E for polar lipids: chloroform:methanol:water
(60:30:6, by vol.) in the first direction, and chloroform:acetic
acid:methanol:water (40:25:3:6, by vol.) in the second direction
(Besra, 1998; Dobson et al., 1985). Plates were dried and autoradio-
grams were produced by overnight exposure of Kodak X-Omat AR film
to the TLC plates to reveal [1,2-
14C]acetate-labelled lipids.
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14C]Acetate incorporation in lipoglycans. Lipoglycans were
extracted from [1,2-
14C]acetate-labelled delipidated cells as previously
described (Ludwiczak et al., 2001). Briefly, cells were broken by
sonication (MSE Soniprep 150, 12 mm amplitude, 60 s on, 90 s off for
10 cycles, on ice) and the cell debris was refluxed five times with 50%
C2H5OH at 68 uC, for 12 h intervals. The cell debris was removed by
centrifugation and the supernatant containing lipoglycans and neutral
glycans was dried. The dried extract was then treated with 80% hot
phenol at 85 uC. The aqueous phase was dialysed and dried, followed
by extensive treatments with a-amylase, DNase, RNase, chymotrypsin
and trypsin to degrade any contamination. This fraction was dialysed
to remove the low-molecular-mass breakdown products formed after
the enzyme treatment, thus yielding the crude lipoglycan fraction.
The crude lipoglycan extract was dried and resuspended in buffer A
(50 mM ammonium acetate and 15% propan-1-ol) and subjected to
Octyl Sepharose CL-4B chromatography. The column (2.5650 cm)
was washed initially with four column volumes of buffer A to ensure
removal of neutral glycans, followed by buffer B (50 mM ammonium
acetate and 50% propan-1-ol). The eluent was collected and
concentrated to approximately 1 ml and precipitated using 5 ml
C2H5OH. The sample was dried using a Savant Speedvac concentrator
and resuspended in water, and the incorporation of [1,2-
14C]acetate
into lipoglycans was determined. Furthermore, 25 mg lipoglycans was
loaded on a 15% SDS-PAGE gel and developed using autoradio-
grams, as described previously (Mishra et al., 2008).
RESULTS AND DISCUSSION
M. marinum MMAR_2380 is essential for the
presence of the mannose cap on LAM
Two genes have been reported to be involved in the
biosynthesis of the mannose cap on ManLAM, Rv1635c
and Rv2181 (Dinadayala et al., 2006; Kaur et al., 2008). An
M. marinum mutant strain in which the homologue of
Rv1635c (MMAR_2439) is mutated has also been isolated
in a colony blot screen with mannose cap-recognizing mAb
55.92.1A1 (anti-ManLAM; a-ManLAM) (Appelmelk et al.,
2008).
By continuing with this screen, we identified a novel gene
involved in mannose-capping. LAM from an M. marinum
mutant strain with a transposon inserted in MMAR_2380
at 91 bp upstream of its 39 end (Supplementary Fig. S2)
reacted well with an anti-AraLAM (a-AraLAM) mAb (mAb
F30-5) which recognizes the arabinan branches of LAM,
but not with a-ManLAM (Fig. 1a). The absence of the
mannose cap on LAM in M. marinum DMMAR_2380 was
further verified by chemical analysis. Both the mono- and
di-mannoside caps, which are the dominant cap-lengths in
the wild-type strain of M. marinum (Pitarque et al., 2005),
were not detectable in the mutant strain (Fig. 1b). By
complementing M. marinum DMMAR_2380 with a wild-
type copy of MMAR_2380 (region indicated in
Supplementary Fig. S2), the biosynthesis of the mannose
cap on LAM was restored (Fig. 1a). This also excluded the
possibility that the transposon affected the treXYZ-operon
located downstream of MMAR_2380 rather than MMAR_
2380 (Supplementary Fig. S2).
Mannosyltransferase capping enzymic activity is
still present in the M. marinum DMMAR_2380
mutant strain
Since the full-length mannose cap is missing in the mutant
strain, we checked the potential capability of the latter to
Fig. 1. Absence of the mannose cap on mutant LAM. (a) Cell lysates from M. marinum wild-type, DMMAR_2380 and
complemented DMMAR_2380 (DMMAR_2380 comp.) strains and M. smegmatis wild-type (control for ‘capless’ LAM) were
immunoblotted with a-AraLAM antibody F30-5, which recognizes LAM, and a-ManLAM antibody 55.92.1A1, which recognizes
the mannose cap. (b) Mannooligosaccharide cap analysis of LAM. Purified and partially degraded LAM was analysed for the
presence of the mannose caps by CE. Shown are the profiles of LAM purified from M. marinum E11 (trace 1) and M. marinum
DMMAR_2380 (trace 2). A, Ara-APTS; M, Man-APTS; S, internal standard, mannoheptose-APTS; AM, Manp-a(1A5)-Ara-
APTS (monomannoside cap); AMM, Manp-a(1A2)-Manp-a(1A5)-Ara-APTS (dimannoside cap).
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mannosyltransferase assay previously set up to characterize
the enzymic activity of the MMAR_2439 (Rv1635c) gene
product (Appelmelk et al., 2008). A membrane preparation
from M. marinum wild-type cells is able to transfer
mannose from an in situ-produced decaprenylphospho-
mannose donor to a synthetic Ara6 acceptor, but a mem-
brane preparation of M. marinum DMMAR_2439 does not
show this enzyme activity (Appelmelk et al., 2008). In
contrast to this previous mutant, a membrane preparation
from M. marinum DMMAR_2380 was able to produce a
mannosylated Ara6 acceptor similar to that of the wild-type
strain (Fig. 2). This means that the arabinan mannose-
capping enzymic activity is still present in the membrane
of M. marinum DMMAR_2380; in other words, the gene
product of MMAR_2380 is not involved in the direct
functioning of the LAM-capping mannosyltransferase.
Structural differences between the glycan parts of
wild-type and mutant LAM
To investigate whether an alteration in the structure of the
arabinan domain of mutant LAM might have caused the
inability of the mutant strain to add the mannose cap, the
glycan part of wild-type and mutant LAM was analysed by
NMR. The NMR profile showed that the mutant LAM
contained all mannosyl (Manp) and arabinosyl (Araf)
residues that are present in the wild-type LAM, even the
single a(1A2)-linked mannoses added to the mannan core
(Fig. 3). Most importantly, the b-arabinosyl residues which
form the non-reducing termini of the branches of the
arabinan domain and which are the acceptors for the
mannose-capping enzyme MMAR_2439 (Supplementary
Fig. S1), were still part of M. marinum DMMAR_2380
LAM, and hence could, at least in theory, become
substituted with a mannose cap.
Further analysis, however, did indicate an increase in the
degree of branching of the mannan core in the mutant
LAM, as revealed by the 2,6-a-Manp:(2,6-a-Manp+6-a-
Manp) ratio, which was 78% in the mutant and 28% in
the wild-type LAM. In a similar way, the arabinan domain
of the mutant LAM seemed to harbour more lateral
branches, with a 2-a-Araf:5-a-Araf ratio of 0.35 in the
mutant as compared with 0.29 in the wild-type LAM.
Methylation analysis corroborated these conclusions,
although the ratio values were somewhat different: the
2,6-a-Manp:(2,6-a-Manp+6-a-Manp) ratio was 50% for
mutant LAM and 36% for the wild-type LAM, and the 2-
a-Araf:5-a-Araf ratio was 0.23 and 0.15 for the mutant and
wild-type LAM, respectively.
Accordingly, in the biosynthesis of ManLAM, the function
of the MMAR_2380 protein appears essential for the
presence of the mannose cap, but its mutation also results
in increased branching of both the mannan core and the
arabinan domain of LAM.
Acylation patterns of lipoglycans from wild-type
and mutant strains
As MMAR_2380 is predicted to contain an acyltransferase
domain, the acylation of mutant LAM was examined. To
investigate this, M. marinum was cultured in the presence of
[1,2-
14C]acetate, after which lipoglycans were extracted and
counted for the incorporation of [1,2-
14C]acetate in the acyl
chains (Fig. 4a). The data show that as compared with
lipoglycans from wild-type M. marinum, lipoglycans from
M. marinum DMMAR_2380 have a reduced [1,2-
14C]acetate
incorporation. The complementation of M. marinum
DMMAR_2380 with wild-type MMAR_2380 resulted in an
increase of [1,2-
14C]acetate incorporation. LAM and the
related lipoglycan lipomannan (LM) were further examined
by SDS-PAGE/autoradiography (Fig. 4a), which also con-
firmed the reduction of [1,2-
14C] acetate incorporation in
the mutantLAMandshoweda similar effectformutantLM.
As similar effects of mutation of MMAR_2380 on
[1,2-
14C]acetate incorporation were seen for LM and LAM,
we also analysed acylation of the structurally related
phosphatidylinositol mannosides (PIMs). [1,2-
14C]acetate-
labelled lipid extracts were examined by 2D TLC using
solvent system E for polar lipids (Besra, 1998; Dobson et al.,
1985), which indeed showed differences in the polar lipid
profiles of the wild-type and mutant strains. The lipid
extract from wild-type M. marinum showed [1,2-
14C]acetate
incorporation into phosphatidylinositol (PI), tri- and tetra-
acylated phosphatidylinositol dimannosides (Ac1/Ac2PIM2)
and phosphatidylinositol hexamannosides (Ac1/Ac2PIM6)
(Fig. 4b). Interestingly, in the lipid profile of M. marinum
DMMAR_2380, a subtle but reproducible reduction in
[1,2-
14C]acetate incorporation in both Ac1PIM6 and
Fig. 2. Enzymic analysis. Mannosyltransferase capping assay with
synthetic Ara6 as acceptor and membranes from M. marinum wild-
type, DMMAR_2380 and complemented DMMAR_2380
(DMMAR_2380 comp.), and as control, membranes from M.
marinum wild-type without acceptor. Shown are means of
triplicates; error bars, SD.
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[1,2-
14C]acetate in Ac1/Ac2PIM2, however, showed some
variations between the experiments, and therefore was less
clear.
Phosphatidylinositol dimannosides (PIM2) have been
hypothesized to be precursors for phosphatidylinositol
hexamannosides (PIM6) as well as LAM and LM, with
phosphatidylinositol tetramannosides (PIM4) as a putative
branching point (Besra et al., 1997; Kovacevic et al., 2006),
and therefore alterations at or before this point of the
biosynthesis pathway of LAM may carry forward into the
final structure of LAM, as well as LM and PIM6. Because
[1,2-
14C]acetate incorporation analysis only provides
information on potential quantitative differences between
the wild-type and mutant lipoglycans, and to verify the
results obtained from the TLC assays, we also subjected
extracted PIMs to direct structural analysis by MALDI-
TOF MS in an independent experiment. This technique
can discriminate between the various forms of PIMs in
terms of mannosylation and acylation (Gilleron et al.,
2006). The crude lipid extract from the mutant strain M.
marinum DMMAR_2380 contained all the different forms
of PIMs present in the wild-type strain but with an
apparent reduction of the most acylated forms (Supple-
mentary Fig. S3), which might explain the decrease of
[1,2-
14C]acetate incorporation in the mutant.
Hence, while LAM, LM and all forms of PIMs are present
in the mutant strain, small quantitative differences in
[1,2-
14C]acetate incorporation in PIMs, LM, and LAM
betweenthewild-typeandthemutant straincanbeobserved,
which might arise from a reduction of the relative abundance
of the most acylated forms.
M. marinum DMMAR_2380 has altered
cell-surface properties
Along with the biosynthesis by M. marinum DMMAR_2380
of LAM that is devoid of the mannose cap, another
phenotypic trait was observed for this mutant strain.
As compared with the wild-type strain, M. marinum
DMMAR_2380 showed severe aggregation. When grown as
liquid cultures in 7H9 medium supplemented with 0.05%
(v/v) Tween 80, the mutant strain showed a reduced OD600
over time as compared with both its parent and the
complemented strain (Fig. 5a). While the wild-type and
complemented strain showed smooth yellow suspensions,
the mutant strains showed aggregation and irregular pink
clumps (Fig. 5b, and Supplementary Fig S4 for colour
pictures). We cannot determine whether MMAR_2380 is
essential for optimal growth in vitro or, alternatively,
whether the reduced OD600 in liquid cultures is solely due
to aggregation. On 7H10 agar plates, the mutant strain
showed the same colony morphology and growth rate as
the wild-type strain (not shown). The effect of mutation of
MMAR_2380 on the cell-surface properties of M. marinum
DMMAR_2380 in liquid cultures was consistent with earlier
reported results for a Mycobacterium avium mutant strain
in which the homologous gene was mutated (Yamazaki
et al., 2006a, b). This M. avium mutant was impaired in its
ability to produce large, wild-type amounts of biofilm
(Yamazaki et al., 2006b), which also negatively influenced
its invasiveness of human bronchial epithelial cells
(Yamazaki et al., 2006a). On the other hand, in a designer
arrays for defined mutant analysis (DeADMAn) screen of a
transposon mutant library in M. tuberculosis CDC1551 for
survival in mice, the mutant strain with a transposon in
the homologous gene (DMT1616) was tested and did not
Fig. 3. NMR analysis of the glyco part of LAM from M. marinum wild-type (pattern 1) and DMMAR_2380 (pattern 2). 2D
1H-
13C heteronuclear multiple quantum coherence spectroscopy (1H-
13C HMQC) spectra of LAM in D2O at 313 K are shown
with expanded regions (d
1H, 4.80–5.35; d
13C, 99–113). The different resonances are labelled with the abbreviated name of
the corresponding glycosyl units. See Supplementary Fig. S1 for structure of ManLAM.
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et al., 2005).
The glycolipid profile and mannosylation pattern
of proteins in M. marinum DMMAR_2380 appear
identical to wild-type patterns
The above-mentioned effect of the transposon insertion in
MMAR_2380, the aggregation of the mutant strain,
suggested a more pleiotropic effect on the bacterial surface,
and hence could have affected, for example, the biosyn-
thesis of glycolipids other than LAM. Other alterations in
phenotypic traits, such as morphology, smooth/rough
transition of colonies and biofilm formation, have often
been linked to changes in glycolipid constituents (Belisle
et al., 1993; Belisle & Brennan, 1989; Daffe ´ et al., 1991;
Howard et al., 2006). Therefore, we performed an extensive
lipid profile study in which polar and apolar extractable
lipids were run in a range of four different TLC solvent
systems, A to D, in addition to system E discussed above.
Strikingly, no differences between the wild-type and the
mutant strain could be observed (Supplementary Fig. S5).
Next, we checked for the mannosylation of proteins in M.
marinum DMMAR_2380 as compared with the wild-type
strain, because of the specific role of MMAR_2380 in the
mannose-capping of LAM. Whole-cell lysates were exam-
Fig. 4. Reduced [1,2-
14C]acetate incorporation in the polar lipids PIM6, LM and LAM from M. marinum DMMAR_2380. (a)
Extracted crude lipoglycans from acetate-labelled delipidated cells (25 mg) from M. marinum wild-type, DMMAR_2380 and
complemented DMMAR_2380 (DMMAR_2380 comp.) were counted for the incorporation of [1,2-
14C]acetate and analysed by
SDS-PAGE/autoradiography. Shown is the average of two independent experiments. (b) [1,2-
14C]Acetate-labelled M. marinum
cultures were processed and polar lipids were applied (25000 c.p.m.) to the corners of 6.66.6 cm pieces of aluminium-
backed TLC plates and analysed using the 2D solvent system E as described in Methods. Plates were dried and
autoradiograms were produced by overnight exposure of Kodak X-Omat AR film to the TLC plates to reveal [1,2-
14C]acetate-
labelled lipids. PI, non-mannosylated, diacylated phosphatidylinositol anchor; PIM2, phosphatidylinositol dimannoside; PIM6,
phosphatidylinositol hexamannoside; Ac1PIM, tri-acylated PIM; Ac2PIM, tetra-acylated PIM. Unassigned spots in the figure are
lipooligosaccharides, and in the upper-right corner are diphosphatidylglycerol, phosphatidylethanolamine and unknown
phospholipids (Burguie `re et al., 2005). Two independently prepared lipid extracts per strain were tested.
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concanavalin A (ConA), which recognizes a-linked man-
nose. Overall, the mannosylation pattern of proteins from
M. marinum DMMAR_2380 appeared similar to those of
mannosylated proteins from the M. marinum wild-type
strain, and the only difference observed in staining was at
the position of (Man-)LAM on the blot (40–45 kDa)
(Supplementary Fig. S6).
Prediction of gene function
MMAR_2380 encodes a 729 aa predicted transmembrane
protein of unknown function (Supplementary Fig. S2).
Therefore, a standard BLASTP search was performed against
the nonredundant (nr) database at NCBI for the protein
MMAR_2380 along with a search against the Conserved
Domain Database (CDD) (Marchler-Bauer et al., 2009). In
contrast to the mannose-capping enzyme Rv1635c,
MMAR_2380 (Rv1565c) is also present with high similarity
in Mycobacterium species known to produce LAM without a
mannose cap, e.g. in M. smegmatis mc
2155 (MSMEG_3187;
identities 75%, positives 85%). Its homologue in M.
tuberculosis strain CDC1551 (MT1616) is annotated as
putative lipopolysaccharide biosynthesis protein WbpC.
Unfortunately, the exact function of the WbpC protein
has not yet been determined. At present, WbpC is annotated
as a possible O-acetyltransferase in the O-antigen biosyn-
thesis cluster of Pseudomonas aeruginosa (King et al., 2009).
The N-terminal half of the protein contains a putative
conserved domain of the acyltransferase-3 superfamily
(Supplementary Fig. S2). As expected, many hits were
found with predicted lipopolysaccharide biosynthesis acyl-
transferases from other non-mycobacterial species that
contain the same conserved domain. MMAR_2380 was
further predicted to be a protein with 10 transmembrane
helices and a large C-terminal tail of approximately 300
amino acids in the periplasm (TMHMM 2.0) (Sonnhammer
et al., 1998).
Considering the effects of mutation of MMAR_2380
described above, we postulate three hypotheses for how
mutation of MMAR_2380 may affect the biosynthesis of
LAM and the related lipoglycans, LM and PIMs. The first
possibility is that MMAR_2380 is a redundant acyltrans-
ferase involved in the acylation of LAM, LM and PIMs. The
phosphatidylinositol synthase required for the MPI anchor
is PgsA1 (encoded by Rv2612c; MMAR_2090 in M.
marinum) (Briken et al., 2004; Jackson et al., 2000), and
acyltransferase Rv2611c has been shown to be involved in
further acylation of PIMs (position C6 of the Manp linked
to the C2 of the inositol) (Kordula ´kova ´ et al., 2003).
Importantly, the Rv2611c-mutant M. smegmatis strains still
produce tri- and tetra-acylated PIMs (Kordula ´kova ´ et al.,
2003), and hence other acyltransferases are yet to be
identified. From the TLC pattern (Fig. 4b), it is not
possible to determine the position of acylation at which
MMAR_2380 may be involved (position C3 of the inositol
or position C6 of the Manp linked to the C2 of the
inositol). However, the differences of [1,2-
14C]acetate
incorporation in PIMs, LAM and LM were small, and
other effects of mutation of MMAR_2380 were observed,
suggesting a different function for MMAR_2380.
A second function for MMAR_2380 could be as a
regulatory protein in the biosynthesis of LAM and related
lipoglycans. The biosynthesis pathway of LAM has recently
become better characterized. Not only glycosyltransferases
directly involved in the addition of mannose and arabinose
have been discovered, but also proteins with a role in the
regulation of this pathway. One of these proteins is
lipoprotein LpqW, which directs PIM4 into the biosyn-
thesis route of LAM (Crellin et al., 2008; Kovacevic et al.,
2006). Furthermore, the production of PIM2 and PIM6 has
been shown to be compartmentalized in separate cell
domains, a plasma membrane domain (PMf) and a plasma
membrane–cell wall domain (PM–CW), respectively, each
Fig. 5. Physical appearance of liquid-grown M. marinum wild type,
DMMAR_2380 and complemented DMMAR_2380 (DMMAR_2380
comp.). (a) OD600 measurements during growth in 7H9+0.05%
Tween 80 with agitation. Shown are means of three independently
grown cultures per strain; error bars SD.( b )M. marinum
DMMAR_2380 shows increased aggregation as compared with
the wild-type and the complemented strains (see Supplementary
Fig. S4 for colour pictures).
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biosynthesis (Morita et al., 2005). Hence, as mutation of
MMAR_2380 resulted in a small quantitative decrease of
[1,2-
14C]acetate incorporation in mutant LAM as well as
LM and PIM6 (Fig. 4), MMAR_2380 may also have a
regulatory function in the metabolic pathway of these
lipoglycans, e.g. in the recruitment of specific enzymes to
the different membrane/cell wall fractions. In addition, as it
is a regulatory protein, mutation of MMAR_2380 could be
the cause of the higher branching degrees of the mutant
LAM, which could subsequently affect the LAM-capping
activity in the mutant strain. Regarding the potential
regulatory role of MMAR_2380, it has been reported that
for certain enzymes additional processing such as acetyla-
tion is essential for proper transport and localization or for
the activity of the enzyme (Banaei et al., 2009; Fukuda
et al., 2002; Tschumi et al., 2009), and MMAR_2380 may
function in this way.
Finally, considering the altered growth of the mutant strain
(Fig. 5), it cannot be excluded that mutation of
MMAR_2380 has a pleiotropic effect on the organization
of the whole cell wall, and that it thus disturbs the
compartmentalized biosynthesis of the higher-order PIM6,
LAM and LM, and/or the transport of lower-order PIM2
from the PMf domain to the PM–CW fraction as precursor
for the other lipoglycans, possibly resulting in the inability
of the mutant strain to produce LAM with a mannose cap.
Summarizing, we have identified a novel gene involved,
possibly indirectly, in the biosynthesis of the mannose cap
on LAM, MMAR_2380, which is the M. marinum
orthologue of Rv1565c. The mutant LAM was not only
devoid of the mannose cap, but also displayed a higher
degree of branching in both the mannan core and the
arabinan domain as compared with wild-type LAM. In
addition, mutation of MMAR_2380 caused small quan-
titative differences in [1,2-
14C]acetate incorporation in
LAM, LM and PIMs, while all the different acylated forms
of the PIMs seen in the wild-type strain were still present.
Furthermore, another effect was seen: M. marinum
DMMAR_2380 showed increased aggregation in liquid
cultures as compared with the wild-type strain, a pheno-
typic trait which was not observed for the previous mutant
M. marinum DMMAR_2439, which produced ‘capless’
LAM. Hence, in all likelihood, MMAR_2380 encodes an
acyltransferase, although neither the length of the acyl
chain transferred nor the acceptor can be predicted.
Acylation activity by MMAR_2380 may be important for
the biosynthesis of the mannose cap in a way which has yet
to be determined.
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